N/A N=66 A Study to Evaluate a New Silicone Hydrogel Contact Lens
Myopia
Primary: Distance High Contrast logMAR Visual Acuity at 1 Week — -0.031; -0.015 logMAR
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=136 Long-term Study of KAD-1229 in Type 2 Diabetes Patients
Type 2 Diabetes
Primary: Incidences of Adverse Events — 48; 57 Participants
Phase 2 N=80 Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma
Sarcoma, Soft Tissue
Primary: Percentage of Patients Hospitalized in Each Arm. — 35; 26 percentage of patients hospitalized
N/A N=2 Interface Kinematics of Transhumeral Prosthetic Sockets Using XROMM
Traumatic Amputation of Arm
Primary: Degrees of Shoulder Abduction Within the Prosthetic Socket — 27; 23.7; 42.5; 20.3 degrees
N/A N=67 Outcomes of Compliance With Brace Wear in Clubfoot
Clubfoot
Primary: Wear Rate Percentage (Number of Hours Per Day Brace Was Worn Out of the Recommended 24 Hours) — 91.7; NA; NA; 86.8 percentage of time worn
Phase 3 N=122 Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Leukaemia
Primary: Progression-free Survival (PFS) as Assessed by Independent Review Committee (IRC) — 5.36; 3.61; 10.05; 7.16 Months — p=0.2677
N/A N=251 Cognitive Problems in Veterans With Heart Failure
Heart Failure · Cognition Disorders
Primary: SLUMS Scores — 24.39 scores on a scale
Phase 1 N=66 Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Cystic Fibrosis
Primary: Safety and Tolerability — 11; 4; 6; 4 participants
Phase 3 N=117 Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression
HIV-1 Infection
Primary: Proportion of Patients With Treatment Failure (TF) — 27.5; 15.4; 7.9; 15.4 percentage of patients
N/A N=187 Predictors of Response to Biventricular Pacing in Heart Failure
Heart Failure, Wide QRS Complex
Primary: Minnesota For Living With Heart Failure Questionnaire — 31; 24 units on a scale
Phase 1 N=20 Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese
Healthy
Primary: Incidence of Adverse Drug Events and Serious Adverse Events — 0; 0; 0; 0 adverse event
N/A N=107 Chiropractic Manipulation and Medical Care for Low Back Pain
Low Back Pain
Primary: Oswestry Low Back Pain Disability Index — -16.0; -8.9; -9.5 units on a scale — p=0.009
N/A N=87,665 From Innovation to Solutions: Childhood Influenza Vaccination Planning
Influenza
Primary: Primary Outcome — 26432; 19352 participants vaccinated out of all — p=<0.05
Phase 3 N=581 Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
Multiple Sclerosis, Relapsing-Remitting
Primary: Percentage of Participants With Sustained Accumulation of Disability (SAD) — 11.12; 8.00 percentage of participants with SAD — p=0.2173
Phase 2 N=44 Sulforaphane-rich Broccoli Sprout Extract for Autism
Autism
Primary: Change From Screening/Baseline in Social Responsiveness Scale (SRS) at 4 Weeks, 10 Weeks, 18 Weeks and 22 Weeks — -7.79; -14.76; -1.38; -14.48 units on a scale